18 relations: Amphetamine, Anorectic, Anticonvulsant, Body mass index, Constipation, Dysgeusia, Food and Drug Administration, Insomnia, New Drug Application, Phenethylamine, Phentermine, Placebo, Risk Evaluation and Mitigation Strategies, Stimulant, Sympathomimetic drug, Topiramate, Vivus, Xerostomia.
Amphetamine (contracted from) is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity.
An anorectic or anorexic is a drug which reduces appetite, resulting in lower food consumption, leading to weight loss.
Anticonvulsants (also commonly known as antiepileptic drugs or as antiseizure drugs) are a diverse group of pharmacological agents used in the treatment of epileptic seizures.
The body mass index (BMI) or Quetelet index is a value derived from the mass (weight) and height of an individual.
Constipation refers to bowel movements that are infrequent or hard to pass.
Dysgeusia, also known as parageusia, is a distortion of the sense of taste.
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Insomnia, also known as sleeplessness, is a sleep disorder where people have trouble sleeping.
The Food and Drug Administration's New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing.
Phenethylamine (PEA) is an organic compound, natural monoamine alkaloid, and trace amine which acts as a central nervous system stimulant in humans.
Phentermine (contracted from phenyl-tertiary-butylamine), also known as α,α-dimethylphenethylamine, is a psychostimulant drug of the substituted amphetamine chemical class, with pharmacology similar to amphetamine.
A placebo is a substance or treatment of no intended therapeutic value.
Risk Evaluation and Mitigation Strategies is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects.
Stimulants (also often referred to as psychostimulants or colloquially as uppers) is an overarching term that covers many drugs including those that increase activity of the central nervous system and the body, drugs that are pleasurable and invigorating, or drugs that have sympathomimetic effects.
Sympathomimetic drugs (also known as adrenergic drugs and adrenergic amines) are stimulant compounds which mimic the effects of endogenous agonists of the sympathetic nervous system.
Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug.
Vivus is a small pharmaceutical company headquartered in Campbell, California, working in obesity, sleep, and sexual health.
Xerostomia, also known as dry mouth and dry mouth syndrome, is dryness in the mouth, which may be associated with a change in the composition of saliva, or reduced salivary flow, or have no identifiable cause.